Skip to main content
OpenTrials

Clinical trial condition

Small-Cell Lymphoma

Explore clinical trials studying Small-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Small-Cell Lymphoma trial results

Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

NCT05947851

Conditions
CLL, Chronic Disease, Disease Attributes, +18 more
Locations
  • Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
  • MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
  • Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
  • Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
View all 55 locations
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

NCT02264574

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator# 0241 La Jolla, California, United States
  • Site Reference ID/Investigator# 0844 Fort Myers, Florida, United States
  • Site Reference ID/Investigator# 0763 West Palm Beach, Florida, United States
  • Site Reference ID/Investigator# 071 Louisville, Kentucky, United States
View all 71 locations
View Trial Details

Related conditions